**5. Conclusion**

MFC plays a pivotal role in every step of the clinical and development process of CAR-T. The repeated validation of MFC assays with clinical efficacy may obtain the best data in future, which will promote the CAR-T study, to obtain the longest *in vivo* proliferation and duration of CAR-T, the best CR rate, the lowest side effects, and the highest survival rate.
